About Us
Help
DUETs
Home
»
Evidence Services Content
»
Evidence Services Content
»
UK Database of Uncertainties about the Effects of Treatments (DUETs) Home
»
Search Results
Help
About us
Contact us
Site map
Search
Search text:
About Uncertainties
Submit an Uncertainty
Bibliographies
Cancer
Cardiovascular diseases
Ear nose and throat disorders
Eyes and vision
Gastroenterological and liver diseases
Haematological disorders
Health policy
Immune system diseases
Infection
Mental health
Musculoskeletal diseases
Neonatal diseases
Neurological conditions
Nutritional metabolic and endocrine disorders
Diabetes
Pernicious anaemia
Thyroid disorders
Trimethylaminuria
Oral and dental conditions
Public health
Respiratory diseases
Service delivery
Skin disorders
Surgery, anaesthesia, perioperative and critical care
Symptoms
Trauma
Urological and genital disorders
Women's health conditions
Nutritional metabolic and endocrine disorders
Total records: 265
From <br />patients
page:
|
|
|
|
|
|
|
|
|
of
< Previous |
export
B12 for pernicious anaemia dosing frequencies based on the patients’ symptoms rather than on number value of serum B12 blood tests
Publication Type:
Known Uncertainty
Publication Date:
21 Dec 2011
View detail
export
The effects of antibiotic treatments on type 2 diabetes and metabolic disorder
Publication Type:
Known Uncertainty
Publication Date:
21 Dec 2011
View detail
export
Do high plasma levels of trimethylamine (TMAO) gut flora metabolism of phosphatidylcholine cause cardiovascular disease?
Publication Type:
Known Uncertainty
Publication Date:
21 Oct 2011
View detail
export
In-vitro screening to test whether ataluren (PTC124) can correct functional consequences of premature termination mutations of the Flavin containing monooxygenase 3 (FMO3) gene?
Publication Type:
Known Uncertainty
Publication Date:
21 Oct 2011
View detail
export
To what extent are individuals with trimethylaminuria, and lack functional hepatic flavin containing monooxygenase 3 (FMO3) substrates, unable to oxidize other odiferous FMO3-specific substrates and does this contribute significantly to body odour?
Publication Type:
Known Uncertainty
Publication Date:
21 Oct 2011
View detail
export
Which bacterial species in the human intestine are responsible for the generation of trimethylamine?
Publication Type:
Known Uncertainty
Publication Date:
21 Oct 2011
View detail
export
Would a comprehensive biochemical screening test for trimethylaminuria help patients?
Publication Type:
Known Uncertainty
Publication Date:
21 Oct 2011
View detail
export
Do probiotics significantly reduce trimethylaminuria (TMAU1) producing bacteria in the human intestine and does this result in clinically relevant decreases in TMA production, and thus body odour, in patients with TMAU1?
Publication Type:
Known Uncertainty
Publication Date:
17 Oct 2011
View detail
export
Does delayed diagnosis and thus treatment of pernicious anaemia cause people to develop adverse effects such as peripheral neuropathy or sub-acute combined degeneration of the spinal cord?
Publication Type:
Known Uncertainty
Publication Date:
28 Sep 2011
View detail
export
Does under treatment of pernicious anaemia cause cyclic cognitive impairment for patients?
Publication Type:
Known Uncertainty
Publication Date:
28 Sep 2011
View detail
|
|
|
|
as
CSV
or
Excel
page:
|
|
|
|
|
|
|
|
|
of
< Previous |
Search results options
Search within results:
Sort by:
Title
Publisher
Publication Date
Publication Type
Show summaries:
Per page:
10
20
50
Sitemap
Terms and Conditions
Contact Us
FAQs
Help
Follow us:
Copyright © 2013 National Institute for Health and Care Excellence. All Rights Reserved.
Provided by
NICE